Roche Holding AG (OTCMKTS:RHHBY) Shares Sold by OLD National Bancorp IN

OLD National Bancorp IN reduced its position in Roche Holding AG (OTCMKTS:RHHBYFree Report) by 0.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 253,991 shares of the company’s stock after selling 1,076 shares during the quarter. OLD National Bancorp IN’s holdings in Roche were worth $10,425,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of RHHBY. Altrius Capital Management Inc boosted its holdings in shares of Roche by 0.3% in the fourth quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock valued at $6,399,000 after acquiring an additional 603 shares during the period. SVB Wealth LLC acquired a new stake in shares of Roche in the fourth quarter valued at approximately $555,000. HighPoint Advisor Group LLC boosted its holdings in shares of Roche by 2.8% in the fourth quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock valued at $387,000 after acquiring an additional 304 shares during the period. Hancock Whitney Corp lifted its holdings in shares of Roche by 6.8% during the fourth quarter. Hancock Whitney Corp now owns 23,516 shares of the company’s stock worth $820,000 after purchasing an additional 1,496 shares during the period. Finally, Minot DeBlois Advisors LLC acquired a new stake in shares of Roche during the fourth quarter worth $752,000.

Analyst Upgrades and Downgrades

RHHBY has been the subject of several recent research reports. Hsbc Global Res downgraded Roche from a “strong-buy” rating to a “hold” rating in a report on Monday, April 28th. HSBC downgraded Roche from a “buy” rating to a “hold” rating in a report on Monday, April 28th. Morgan Stanley initiated coverage on Roche in a report on Wednesday, February 12th. They set an “equal weight” rating for the company. Finally, UBS Group raised Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

Get Our Latest Analysis on Roche

Roche Trading Up 0.2%

OTCMKTS:RHHBY opened at $40.86 on Friday. The stock has a fifty day moving average price of $39.14 and a two-hundred day moving average price of $38.86. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86. Roche Holding AG has a 1 year low of $33.30 and a 1 year high of $44.31.

Roche Profile

(Free Report)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

Featured Articles

Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBYFree Report).

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.